Brief: Evoke Announces Teva Ends Pursuit Of Paragraph IV ANDA Against Gimoti
Jan 30 (Reuters) - Evoke Pharma Inc EVOK.O :
* EVOKE ANNOUNCES TEVA ENDS PURSUIT OF PARAGRAPH IV ANDA
AGAINST
GIMOTI
* EVOKE PHARMA - IN ADDITION, NO FUTURE ANDA FILER WILL BE
ELIGIBLE TO RECEIVE 180-DAY GENERIC EXCLUSIVITY FOR AN ANDA THAT
REFERENCES GIMOTI
Source text for Eikon: ID:nGNXrcbM
Further company coverage: EVOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary